Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
Butler LM, Mah CY, Machiels J, Vincent AD, Irani S, Mutuku SM, Spotbeen X, Bagadi M, Waltregny D, Moldovan M, Dehairs J, Vanderhoydonc F, Bloch K, Das R, Stahl J, Kench JG, Gevaert T, Derua R, Waelkens E, Nassar ZD, Selth LA, Trim PJ, Snel MF, Lynn DJ, Tilley WD, Horvath LG, Centenera MM, Swinnen JV. Butler LM, et al. Among authors: waelkens e. Cancer Res. 2021 Oct 1;81(19):4981-4993. doi: 10.1158/0008-5472.CAN-20-3863. Epub 2021 Aug 6. Cancer Res. 2021. PMID: 34362796
Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype.
Swinnen JV, Beckers A, Brusselmans K, Organe S, Segers J, Timmermans L, Vanderhoydonc F, Deboel L, Derua R, Waelkens E, De Schrijver E, Van de Sande T, Noël A, Foufelle F, Verhoeven G. Swinnen JV, et al. Among authors: waelkens e. Cancer Res. 2005 Mar 15;65(6):2441-8. doi: 10.1158/0008-5472.CAN-04-3025. Cancer Res. 2005. PMID: 15781660 Free article.
Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigen.
Van den Bergh K, Hooijkaas H, Blockmans D, Westhovens R, Op De Beéck K, Verschueren P, Dufour D, van de Merwe JP, Fijak M, Klug J, Michiels G, Devogelaere B, De Smedt H, Derua R, Waelkens E, Blanckaert N, Bossuyt X. Van den Bergh K, et al. Among authors: waelkens e. Clin Chem. 2009 May;55(5):946-54. doi: 10.1373/clinchem.2008.115626. Epub 2009 Mar 5. Clin Chem. 2009. PMID: 19264855
Specific regulation of protein phosphatase 2A PR72/B'' subunits by calpain.
Janssens V, Derua R, Zwaenepoel K, Waelkens E, Goris J. Janssens V, et al. Among authors: waelkens e. Biochem Biophys Res Commun. 2009 Sep 4;386(4):676-81. doi: 10.1016/j.bbrc.2009.06.096. Epub 2009 Jun 23. Biochem Biophys Res Commun. 2009. PMID: 19555667 Free article.
Seroreactivity against glycolytic enzymes in inflammatory bowel disease.
Vermeulen N, Vermeire S, Arijs I, Michiels G, Ballet V, Derua R, Waelkens E, Van Lommel L, Schuit F, Rutgeerts P, Bossuyt X. Vermeulen N, et al. Among authors: waelkens e. Inflamm Bowel Dis. 2011 Feb;17(2):557-64. doi: 10.1002/ibd.21388. Inflamm Bowel Dis. 2011. PMID: 20629101
De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation.
Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, Van Veldhoven PP, Waltregny D, Daniëls VW, Machiels J, Vanderhoydonc F, Smans K, Waelkens E, Verhoeven G, Swinnen JV. Rysman E, et al. Among authors: waelkens e. Cancer Res. 2010 Oct 15;70(20):8117-26. doi: 10.1158/0008-5472.CAN-09-3871. Epub 2010 Sep 28. Cancer Res. 2010. PMID: 20876798
194 results